.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Boehringer Ingelheim
Chubb
Colorcon
Accenture
AstraZeneca
Express Scripts
Cantor Fitzgerald
Queensland Health
Harvard Business School

Generated: December 15, 2017

DrugPatentWatch Database Preview

PHENYLEPHRINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Phenylephrine Hydrochloride, and when can generic versions of Phenylephrine Hydrochloride launch?

Phenylephrine Hydrochloride is a drug marketed by Akorn Inc, Paragon Bioteck, West Ward Pharm Corp, Hi-tech Pharmacal, and Vintage. and is included in five NDAs. There is one patent protecting this drug.

This drug has one patent family member in one country and two supplementary protection certificates in two countries.

The generic ingredient in PHENYLEPHRINE HYDROCHLORIDE is phenylephrine hydrochloride; promethazine hydrochloride. There are twenty drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the phenylephrine hydrochloride; promethazine hydrochloride profile page.
Drug patent expirations by year for PHENYLEPHRINE HYDROCHLORIDE

Pharmacology for PHENYLEPHRINE HYDROCHLORIDE

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn IncPHENYLEPHRINE HYDROCHLORIDEphenylephrine hydrochlorideSOLUTION/DROPS;OPHTHALMIC207926-001Jan 15, 2015RXYesYes► Subscribe► Subscribe► Subscribe
VintagePHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDEphenylephrine hydrochloride; promethazine hydrochlorideSYRUP;ORAL040654-001Dec 7, 2006AARXNoNo► Subscribe► Subscribe► Subscribe
Paragon BioteckPHENYLEPHRINE HYDROCHLORIDEphenylephrine hydrochlorideSOLUTION/DROPS;OPHTHALMIC203510-002Mar 21, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Akorn IncPHENYLEPHRINE HYDROCHLORIDEphenylephrine hydrochlorideSOLUTION/DROPS;OPHTHALMIC207926-002Jan 15, 2015RXYesYes► Subscribe► Subscribe► Subscribe
Paragon BioteckPHENYLEPHRINE HYDROCHLORIDEphenylephrine hydrochlorideSOLUTION/DROPS;OPHTHALMIC203510-001Mar 21, 2013RXYesYes► Subscribe► Subscribe► Subscribe
Hi-tech PharmacalPHENYLEPHRINE HYDROCHLORIDE AND PROMETHAZINE HYDROCHLORIDEphenylephrine hydrochloride; promethazine hydrochlorideSYRUP;ORAL040675-001Dec 23, 2014AARXNoNo► Subscribe► Subscribe► Subscribe
West Ward Pharm CorpPHENYLEPHRINE HYDROCHLORIDEphenylephrine hydrochlorideSOLUTION;IV (INFUSION)203826-001Dec 20, 2012RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: PHENYLEPHRINE HYDROCHLORIDE

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2015073696► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: PHENYLEPHRINE HYDROCHLORIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
923Luxembourg► SubscribePRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730
C0090France► SubscribePRODUCT NAME: SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; REGISTRATION NO/DATE: EU/1/15/1018 20150728
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Boehringer Ingelheim
Teva
Chinese Patent Office
Fuji
Healthtrust
Cerilliant
Deloitte
Queensland Health
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot